Ryu J K, Stern R L, Robinson M G, Bowers M K, Kubo H D, Donald P J, Rosenthal S A, Fu K K
Department of Surgery, University of California Davis, Sacramento 95817, USA.
Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):627-34. doi: 10.1016/0360-3016(95)00074-9.
To evaluate the soft tissue and bone tolerance of radiation therapy (RT) in patients undergoing radical composite resection and mandibular reconstruction using a bridging titanium plate with myocutaneous flap closure.
From 1990 to 1994, 47 patients with primary or recurrent oral cavity or oropharyngeal carcinomas were treated with radical composite resection and mandibular reconstruction using a bridging titanium plate with myocutaneous flap closure. Eleven patients received no RT (no RT), 10 patients received RT greater than 10 months from the time of surgery (remote RT), and 26 patients received RT within 12 weeks of surgery (perioperative RT). The radiation dose to the reconstructed mandible ranged from 45 to 75 Gy (median 63 Gy). The effect of the titanium plate on the radiation dose was measured using film dosimetry and soft tissue and bone-equivalent materials. The median follow-up was 17 months (range: 3-50 months).
Late complications included four patients with osteomyelitis or necrosis, two plate exposures requiring flap revision, one chronic infection, two cases of chronic pain, two fistulae, and one case of trismus and malocclusion. The crude incidence of late complications by treatment was: (a) no RT: 3 of 11 patients (27%); (b) remote RT: 2 of 10 patients (20%); and (c) perioperative RT: 9 of 26 patients (35%). One patient in the no-RT group lost the plate due to chronic pain. Five patients in the perioperative RT group also had plate loss, four due to osteomyelitis and/or necrosis, and one due to pain related to a recurrent tumor. No patients in the remote RT group had plate loss. The actuarial prosthesis preservation rate at 2 years was 88% for the no RT, 100% for the remote RT, and 57% for the perioperative RT groups (p = 0.05). Phantom dose measurements showed that for parallel opposed 6 MV photon beams, there was no significant increase in the dose proximal or distal to the plate in either a soft tissue- or bone-equivalent phantom.
The impact of radiation therapy on plate preservation after mandibular reconstructive surgery using a titanium plate may be dependent on the timing of RT relative to surgery. Significantly more mandibular reconstruction plates were lost when the involved mandible received RT in the perioperative period than when RT was delivered beyond 10 months from surgery or when no RT was given. The use of alloplastic implants such as titanium plates in conjunction with myocutaneous flap coverage for mandibular reconstruction is attractive because it allows immediate reconstruction of the defect and promotes a good functional and cosmetic result; however, administration of perioperative RT may result in a higher plate failure rate.
评估采用带肌皮瓣闭合的桥接钛板行根治性复合切除及下颌骨重建的患者接受放射治疗(RT)时的软组织和骨耐受性。
1990年至1994年,47例原发性或复发性口腔或口咽癌患者接受了采用带肌皮瓣闭合的桥接钛板的根治性复合切除及下颌骨重建。11例患者未接受放疗(未放疗),10例患者在手术后超过10个月接受放疗(远期放疗),26例患者在手术后12周内接受放疗(围手术期放疗)。重建下颌骨的放射剂量范围为45至75 Gy(中位数63 Gy)。使用胶片剂量测定法以及软组织和骨等效材料测量钛板对放射剂量的影响。中位随访时间为17个月(范围:3至50个月)。
晚期并发症包括4例骨髓炎或坏死患者、2例需要皮瓣修复的钛板外露患者、1例慢性感染患者、2例慢性疼痛患者、2例瘘管患者以及1例牙关紧闭和错牙合患者。按治疗方式统计的晚期并发症粗发病率为:(a)未放疗:11例患者中有3例(27%);(b)远期放疗:10例患者中有2例(20%);(c)围手术期放疗:26例患者中有9例(35%)。未放疗组中有1例患者因慢性疼痛丢失了钛板。围手术期放疗组中有5例患者也出现了钛板丢失,4例是由于骨髓炎和/或坏死,1例是由于与复发性肿瘤相关的疼痛。远期放疗组中没有患者出现钛板丢失。未放疗组、远期放疗组和围手术期放疗组在2年时的假体保留率分别为88%、100%和57%(p = 0.05)。模体剂量测量表明,对于平行相对的6 MV光子束,在软组织或骨等效模体中,钛板近端或远端的剂量均无显著增加。
放射治疗对使用钛板进行下颌骨重建手术后钛板保留的影响可能取决于放疗相对于手术的时间。当受累下颌骨在围手术期接受放疗时,丢失的下颌骨重建钛板明显多于手术10个月后接受放疗或未接受放疗的情况。使用钛板等异体植入物结合肌皮瓣覆盖进行下颌骨重建很有吸引力,因为它可以立即修复缺损并促进良好的功能和美容效果;然而,围手术期放疗可能导致更高的钛板失败率。